OpportunityDeadline:
Scientific venture capital program IndieBio (backed by global deep-tech fund SOSV in San Francisco and New York) opens its 2027 call offering USD 275,000 to USD 525,000 in seed investment plus 4 months of free BSL-1/BSL-2 wet-lab and computational lab access to turn life science, clinical diagnostics, and health research into companies. Deadline: February 20, 2027.